These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37116048)

  • 1. Late Onset Pompe's Disease: Clinical, Pathological & Molecular Analysis of Two Adolescent Patients.
    Parameswaran AS; Singh ; Saini L; Aggarwal D
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A retrospective study of six patients with late-onset Pompe disease].
    Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
    Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygotic intronic GAA mutation in three siblings with late-onset Pompe's disease.
    Grzesiuk AK; Shinjo SM; da Silva R; Machado M; Galera MF; Marie SK
    Arq Neuropsiquiatr; 2010 Apr; 68(2):194-7. PubMed ID: 20464284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enzyme replacement therapy in Pompe's disease].
    Merk T; Wibmer T; Schumann C; Krüger S
    Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable Genotype-Phenotype Correlation of Pompe's Disease Caused by a c.2015 G > A (p.Arg672Gln) Mutation in the GAA Gene.
    Tokatly Latzer I; Sagi L; Bali DS; Rehder C; Orbach R; Fattal-Valevski A
    Neuropediatrics; 2021 Dec; 52(6):475-479. PubMed ID: 33578445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke in Young-Dilative Arteriopathy: A Clue to Late-Onset Pompe's Disease?
    Huded V; Bohra V; Prajapati J; DeSouza R; Ramankutty R
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):e50-2. PubMed ID: 26853144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.
    Rairikar MV; Case LE; Bailey LA; Kazi ZB; Desai AK; Berrier KL; Coats J; Gandy R; Quinones R; Kishnani PS
    Mol Genet Metab; 2017 Nov; 122(3):99-107. PubMed ID: 28951071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset Pompe's disease.
    Teener JW
    Semin Neurol; 2012 Nov; 32(5):506-11. PubMed ID: 23677658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [First cases of Pompe's disease in Kazakhstan].
    Zharkinbekova NA; Mukhambetova GA; Kaishibayeva GS; Zhiyenbayeva BS; Zhumagulova KB; Kaishibayev SN; Iglikova AE; Suleimanova SY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):85-87. PubMed ID: 28884723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and molecular genetic study on two patients of the juvenile form of Pompe disease in China].
    Qiu JJ; Wei M; Zhang WM; Shi HP
    Zhonghua Er Ke Za Zhi; 2007 Oct; 45(10):760-4. PubMed ID: 18211760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pompe's disease or type IIa glycogenosis.
    Jacob JL; Leandro RL; Parro Junior A
    Arq Bras Cardiol; 1999 Nov; 73(5):435-40. PubMed ID: 10887364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up.
    Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT
    Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pompe's disease. Part I: pathogenesis and clinical features].
    Illés Z; Trauninger A
    Ideggyogy Sz; 2009 Jul; 62(7-8):231-43. PubMed ID: 19685701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood Pompe disease: clinical spectrum and genotype in 31 patients.
    van Capelle CI; van der Meijden JC; van den Hout JM; Jaeken J; Baethmann M; Voit T; Kroos MA; Derks TG; Rubio-Gozalbo ME; Willemsen MA; Lachmann RH; Mengel E; Michelakakis H; de Jongste JC; Reuser AJ; van der Ploeg AT
    Orphanet J Rare Dis; 2016 May; 11(1):65. PubMed ID: 27189384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pompe's Disease in Childhood: A Metabolic Myopathy.
    Raju U; Shaw SC; Rana KS; Sharma M; Ramamurthy HR
    Med J Armed Forces India; 2010 Jan; 66(1):32-6. PubMed ID: 27365701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemia.
    Spada M; Porta F; Vercelli L; Pagliardini V; Chiadò-Piat L; Boffi P; Pagliardini S; Remiche G; Ronchi D; Comi G; Mongini T
    Mol Genet Metab; 2013 Jun; 109(2):171-3. PubMed ID: 23566438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
    Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of Pompe's disease: case report and review of literature.
    Jegadeeswari A; Amuthan V; Janarthanan RA; Murugan S; Balasubramanian S
    Indian Heart J; 2012; 64(2):214-6. PubMed ID: 22572506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical manifestations, course and outcome of enzyme replacement therapy in Hungarian patients with Pompe's disease].
    Bereznai B; Trauninger A; György I; Szakszon K; Almássy Z; Pál E; Herczegfalvi A; Várdi Visy K; Illés Z; Molnár MJ
    Orv Hetil; 2011 Sep; 152(39):1569-75. PubMed ID: 21920843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
    Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
    Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.